These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10655109)

  • 1. Maspin is an angiogenesis inhibitor.
    Zhang M; Volpert O; Shi YH; Bouck N
    Nat Med; 2000 Feb; 6(2):196-9. PubMed ID: 10655109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis.
    Li Z; Shi HY; Zhang M
    Oncogene; 2005 Mar; 24(12):2008-19. PubMed ID: 15688005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.
    Shi HY; Zhang W; Liang R; Abraham S; Kittrell FS; Medina D; Zhang M
    Cancer Res; 2001 Sep; 61(18):6945-51. PubMed ID: 11559574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells.
    Abraham S; Zhang W; Greenberg N; Zhang M
    J Urol; 2003 Mar; 169(3):1157-61. PubMed ID: 12576872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headpin: a serpin with endogenous and exogenous suppression of angiogenesis.
    Shellenberger TD; Mazumdar A; Henderson Y; Briggs K; Wang M; Chattopadhyay C; Jayakumar A; Frederick M; Clayman GL
    Cancer Res; 2005 Dec; 65(24):11501-9. PubMed ID: 16357159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.
    Zhang M; Shi Y; Magit D; Furth PA; Sager R
    Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
    Ramesh R; Mhashilkar AM; Tanaka F; Saito Y; Branch CD; Sieger K; Mumm JB; Stewart AL; Boquoi A; Dumoutier L; Grimm EA; Renauld JC; Kotenko S; Chada S
    Cancer Res; 2003 Aug; 63(16):5105-13. PubMed ID: 12941841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin reduces prostate cancer metastasis to bone.
    Hall DC; Johnson-Pais TL; Grubbs B; Bernal R; Leach RJ; Padalecki SS
    Urol Oncol; 2008; 26(6):652-8. PubMed ID: 18367129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis.
    Reimer CL; Agata N; Tammam JG; Bamberg M; Dickerson WM; Kamphaus GD; Rook SL; Milhollen M; Fram R; Kalluri R; Kufe D; Kharbanda S
    Cancer Res; 2002 Feb; 62(3):789-95. PubMed ID: 11830534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
    Zou Z; Zhang W; Young D; Gleave MG; Rennie P; Connell T; Connelly R; Moul J; Srivastava S; Sesterhenn I
    Clin Cancer Res; 2002 May; 8(5):1172-7. PubMed ID: 12006534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
    Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
    J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma linolenic acid regulates expression of maspin and the motility of cancer cells.
    Jiang WG; Hiscox S; Horrobin DF; Bryce RP; Mansel RE
    Biochem Biophys Res Commun; 1997 Aug; 237(3):639-44. PubMed ID: 9299418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.